<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2015</study_start_year><condition>Cancer-Bowel-Back passage (rectum) or large bowel (colon)</condition><condition>Cancer-Liver</condition><condition>Resection of colorectal liver metastases</condition><condition>Surgery-Surgical techniques</condition><disease>Surgery-surgical Techniques</disease><disease>Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)</disease><disease>Resection Of Colorectal Liver Metastases</disease><disease>Cancer-liver</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2462248</full_dataset_link><location>New Zealand</location><location>Australia</location><study_start_month>9</study_start_month><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>In colorectal metastases patients who require liver resection, does a surgeon having knowledge of liver fat measurements influence surgical planning decisions that result in improved patient outcomes.</name><description>Intervention arm – the surgeon will have knowledge of a quantitative measure of liver fat from MRI (HepaFat-Scan)
Primary Outcome 1: all cause mortality as assessed by data linkage to medical records[Timepoint: within 3 months post surgery];Primary Outcome 2: postoperative complications as assessed by data linkage to medical records (e.g. ascites, urine infection, bilioma, renal failure)[Timepoint: at baseline and 6 months post surgery];Primary Outcome 3: deviations from standard surgical treatment as assessed by qualitative questionnaire designed specifically for this study[Timepoint: baseline]
Study Design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Safety/efficacy</description><dates><creation>2015-09-15</creation></dates><accession>2462248</accession><cross_references><Australian New Zealand Clinical Trials Registry>ACTRN12615000567527</Australian New Zealand Clinical Trials Registry></cross_references></HashMap>